Suppr超能文献

基因组测序和携带者检测:关于分类的决策以及是否披露携带者检测结果。

Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing.

机构信息

Department of Medical Genetics, Kaiser Permanente Northwest, Portland, Oregon, USA.

Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.

出版信息

Genet Med. 2017 Jul;19(7):803-808. doi: 10.1038/gim.2016.198. Epub 2017 Jan 12.

Abstract

PURPOSE

We investigated the use of genome sequencing for preconception carrier testing. Genome sequencing could identify one or more of thousands of X-linked or autosomal recessive conditions that could be disclosed during preconception or prenatal counseling. Therefore, a framework that helps both clinicians and patients understand the possible range of findings is needed to respect patient preferences by ensuring that information about only the desired types of genetic conditions are provided to a given patient.

METHODS

We categorized gene-condition pairs into groups using a previously developed taxonomy of genetic conditions. Patients could elect to receive results from these categories. A Return of Results Committee (RORC) developed inclusion and exclusion criteria for each category.

RESULTS

To date, the RORC has categorized 728 gene-condition pairs: 177 are categorized as life span-limiting, 406 are categorized as serious, 93 are categorized as mild, 41 are categorized as unpredictable, and 11 are categorized as adult-onset. An additional 64 gene-condition pairs were excluded from reporting to patients or put on a watch list, generally because evidence that a gene and condition were associated was limited.

CONCLUSION

Categorization of gene-condition pairs using our taxonomy simplifies communication regarding patient preferences for carrier information from a genomic test.Genet Med advance online publication 12 January 2017.

摘要

目的

我们研究了使用基因组测序进行孕前携带者检测。基因组测序可以识别出数千种 X 连锁或常染色体隐性遗传病中的一种或多种,这些疾病可以在孕前或产前咨询中披露。因此,需要一个框架来帮助临床医生和患者了解可能的发现范围,通过确保只向特定患者提供所需类型的遗传疾病信息,来尊重患者的偏好。

方法

我们使用先前开发的遗传疾病分类法将基因-疾病对分类成组。患者可以选择接收这些类别的结果。一个回报结果委员会(RORC)为每个类别制定了纳入和排除标准。

结果

迄今为止,RORC 已经对 728 对基因-疾病进行了分类:177 对被归类为寿命受限,406 对被归类为严重,93 对被归类为轻度,41 对被归类为不可预测,11 对被归类为成年发病。另外 64 对基因-疾病对被排除在向患者报告或列入观察名单之外,通常是因为证据表明基因和疾病之间存在关联的证据有限。

结论

使用我们的分类法对基因-疾病对进行分类,简化了关于患者对基因组检测携带者信息偏好的沟通。遗传医学在线发表 2017 年 1 月 12 日。

相似文献

引用本文的文献

本文引用的文献

9
ClinGen--the Clinical Genome Resource.ClinGen——临床基因组资源。
N Engl J Med. 2015 Jun 4;372(23):2235-42. doi: 10.1056/NEJMsr1406261. Epub 2015 May 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验